MobiHealth News September 13, 2018
Jonah Comstock

The announcement has drawn questions about novelty and claims of coziness with the FDA.

Yesterday, Apple dropped a bombshell on the digital health world, as it is prone to do in its highly-produced launch events. While the announcement included fall detection on the Apple Watch and some improvements to heart rate monitoring, the headline was definitely the announcement that the Apple Watch Series 4 would contain an FDA-cleared ECG sensor.

While much of the reaction has been positive, longtime watchers of Apple’s health initiatives noticed a few things that didn’t add up: Apple CTO Jeff William’s questionable claim that the ECG is the first of its kind, and the uncanny timing of the announcement and clearance that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, mHealth, Patient / Consumer, Technology, Wearables
Apple’s latest AI research could completely transform your iPhone
New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis
Apple can now assess your risk for depression, anxiety
Samsung, b.well partner to collect health data on Galaxy smartphones
Samsung, b.well partner to provide longitudinal data to Galaxy smartphone users

Share This Article